
Opinion|Videos|June 24, 2024
Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer
A panel of experts on prostate cancer discuss the role for fusion-guided biopsies in active surveillance for patients with prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Is there a role for fusion-guided biopsies in active surveillance for patients with prostate cancer?
- Historically what has been the standard approach for active surveillance? Which patients? How often do you monitor?
- How can fusion-guided biopsies improve surveillance strategies and inform treatment and management decisions to improve outcomes?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
5















